Blood test for Alzheimer’s begins clinical trials
Israeli biotech NeuroQuest set to start US clinical trial of its simple test to diagnose the dreaded brain disorder in older individuals at risk.
Israeli biotech NeuroQuest set to start US clinical trial of its simple test to diagnose the dreaded brain disorder in older individuals at risk.
ISRAEL21c compiles a list of the 10 most extraordinary medical devices and pharmaceuticals that promise to revolutionize global healthcare.
An Israeli company’s experimental blood test can detect dementia while the disease is still mild enough to treat more effectively.